Vimarsana
Biggest News Aggregation in the World

Page 18 - Mc Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mc Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mc Services Today - Breaking & Trending Today

EQS-News: Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference - Vimarsana News

EQS-News: Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference

Issuer: Mainz BioMed N.V. / Key word(s): Conference Mainz Biomed to Present at the Cantor Fitzgerald Global Health...

Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference - Vimarsana News

Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference

BERKELEY, Calif. and MAINZ, Germany, Sept. 20, 2023 -- Mainz Biomed N.V. , a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that Guido...

Mainz Biomed to Present at the Cantor Fitzgerald Global - Vimarsana News

Mainz Biomed to Present at the Cantor Fitzgerald Global

BERKELEY, Calif. and MAINZ, Germany, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular...

EQS-News: Heidelberg Pharma AG: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101 - Vimarsana News

EQS-News: Heidelberg Pharma AG: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101

EQS-News: Heidelberg Pharma AG / Key word(s): Study Heidelberg Pharma AG: Heidelberg Pharma Provides Update on Phas...

Heidelberg Pharma AG: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101 -September 19, 2023 at 01:13 am EDT - Vimarsana News

Heidelberg Pharma AG: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101 -September 19, 2023 at 01:13 am EDT

EQS-News: Heidelberg Pharma AG / Key word: Study Heidelberg Pharma AG: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101...